Maraviroc is used in treatment of:: (A) CMV, (B) HSV, (C) HIV, (D) Measles
Answer is C. Maraviroc binds specifically and selectively to CCR5, one of two coreceptors necessary for entrance of HIV into CD4+ cells, thus blocking entry of CCR5-tropic HIV into these cells. Ref: Katzung 11th edition Chapter 49.